Chromium (Cr)
Glucose metabolism trace element - glycemic regulation and weight
Updated
Overview
Glucose metabolism trace element - glycemic regulation and weight
Oligotherapy Profile
- Symbol
- Cr
- Ménétrier Diathesis
- Adaptation_syndrome
- Terrain Type
- Metabolic
- Typical Dose
- 0.05-0.2mg
Therapeutic Properties
- Glucose tolerance factor (GTF)
- Insulin regulator
- Cravings reducer
- Lipid optimizer
- Thermogenic
Indications
- Prediabetes
- Insulin resistance
- Sugar cravings
- Abdominal overweight
- Hypercholesterolemia
- Metabolic syndrome
Recommended Dosage
1 ampoule daily before lunch. 2-3 month course, renewable.
Contraindications
- Severe kidney failure
- Chromium allergy
- Insulin-dependent diabetes (close monitoring)
Safety Profile
- Pregnancy : âś— Not recommended
- Breastfeeding : âś— Not recommended
- Children : âś— Not recommended
References
- Anderson RA. Chromium, glucose intolerance and diabetes. J Am Coll Nutr. 1998